Elie Lobel

CEO RDS at Rhythm Diagnostic Systems (France)

Elie Lobel has a diverse and extensive work experience in the healthcare and medtech industry. Elie'smost recent role is as the CEO of RDS (Rhythm Diagnostic Systems), a digital medtech company. In this position, they are responsible for developing solutions for patient monitoring in acute stages of their clinical pathway.

Prior to their current role, Lobel served as the CEO of Orange Healthcare at Orange Business Services. Here, they delivered digital and health IT services to various healthcare organizations and oversaw the acquisition of Enovacom, a software company specializing in ehealth data interoperability.

Before joining Orange Business Services, Lobel worked at ASIP Santé, a governmental agency responsible for developing and deploying eHealth programs in France. As the Director of the national & european eHealth projects department, they managed several projects, including the national electronic Patient Health Record infrastructure and European eHealth projects.

Earlier in their career, Lobel worked as the Director of Sales and Business Development at e(ye)BRAIN and held the position of Scientific Director and Director of the eHealth business unit at Doctissimo, a French start-up specializing in eHealth and Health Innovations consulting.

Overall, Elie Lobel has a proven track record of leadership and expertise in the healthcare and medtech industry, with a focus on digital and eHealth solutions.

Elie Lobel has a diverse and extensive education history. Starting in 1987, they attended Lycée Louis-le-Grand, where they pursued a degree in Classes Préparatoires with a focus on Maths Sup et Spé. Elie continued their education at CentraleSupélec from 1989 to 1992, earning an MEng degree in Operations Research. In 1991, Elie Lobel also attended Cornell University for a year, where they pursued a Master of Engineering (MEng) degree in Operations Research. Finally, from 1995 to 2000, they attended Pierre and Marie Curie University, where they obtained their PhD in Neuroimaging.

Links


Timeline

  • CEO RDS

    February, 2020 - present